Table 2.
Variable | HFNC group (43) | CPAP group (41) | P-value |
---|---|---|---|
PRIMARY OUTCOMES | |||
Duration of stay in the hospital, days | 8 (7–9) | 8(7–9) | p = 0.461 |
Duration of non-invasive respiratory support, days | 2 (2–3) | 3 (2–3) | p = 0.090 |
Transfer to the ICU, no. (%) | 6 (14) | 4 (10) | p = 0.553 |
Intubation, no. (%) | 6 (14) | 4 (10) | p = 0.553 |
Mortality, no. (%) | 0 | 0 | — |
Use of sedatives, no. (%) | 17 (40) | 34 (83) | p = 0.000 |
Adverse events, no. (%) | 2 (5) | 11 (27) | p = 0.005 |
Serious adverse event | 0 | 0 | — |
Abdominal distension, no. (%) | 2 (5) | 7 (17) | p = 0.066 |
Pneumothorax | 0 | 0 | — |
Cardiac arrest | 0 | 0 | — |
Respiratory arrest | 0 | 0 | — |
Apnea episodes | 0 | 0 | — |
Skin lesions, no. (%) | 0 | 4 (10) | p = 0.036 |
Comparison of primary outcomes between the two groups [cases (%)]. Values are expressed as mean (SD) ±SD or numbers (%).